Company research / TKNO

Alpha Teknova, Inc. (TKNO)

CIK 0001850902 · Nasdaq · In Vitro & In Vivo Diagnostic Substances

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Alpha Teknova, Inc. reported revenue of $40.52M. Revenue grew 7.4% from the prior annual period.

Key ratios (year ended 2025-12-31)

33.2%
Gross margin
-41.9%
Operating margin
-42.6%
Net margin
-25.1%
Return on year-end equity
7.4%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 10-Q · 2026-08-06

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.